Dnca Finance increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 111.6% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,050 shares of the medical equipment provider’s stock after acquiring an additional 11,100 shares during the quarter. Dnca Finance’s holdings in Intuitive Surgical were worth $11,439,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also bought and sold shares of the stock. Norway Savings Bank raised its holdings in Intuitive Surgical by 53.4% during the second quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock worth $1,420,000 after buying an additional 910 shares during the last quarter. Trust Co. of Oklahoma bought a new stake in shares of Intuitive Surgical during the second quarter worth about $363,000. IronOak Wealth LLC. bought a new stake in shares of Intuitive Surgical during the second quarter worth about $1,099,000. Amalgamated Bank raised its holdings in shares of Intuitive Surgical by 2.2% in the 2nd quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock worth $44,311,000 after acquiring an additional 1,772 shares during the last quarter. Finally, Neville Rodie & Shaw Inc. lifted its position in Intuitive Surgical by 11.9% in the 2nd quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock valued at $5,666,000 after acquiring an additional 1,110 shares in the last quarter. 83.64% of the stock is owned by institutional investors.
Intuitive Surgical Price Performance
Shares of NASDAQ:ISRG opened at $575.34 on Friday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The company has a market capitalization of $206.25 billion, a PE ratio of 76.10, a price-to-earnings-growth ratio of 5.29 and a beta of 1.68. The business has a fifty day moving average price of $518.60 and a two-hundred day moving average price of $505.33.
Analyst Upgrades and Downgrades
A number of brokerages have commented on ISRG. Sanford C. Bernstein reissued an “outperform” rating and set a $685.00 price objective on shares of Intuitive Surgical in a report on Tuesday, October 21st. Robert W. Baird set a $655.00 price target on Intuitive Surgical in a report on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Jefferies Financial Group lifted their price objective on shares of Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a report on Wednesday, October 22nd. Finally, Daiwa Capital Markets increased their target price on shares of Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a report on Friday, October 24th. Two analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $607.17.
Get Our Latest Stock Report on Intuitive Surgical
Insider Activity
In other Intuitive Surgical news, EVP Henry L. Charlton sold 13,731 shares of the stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the transaction, the executive vice president directly owned 3,056 shares of the company’s stock, valued at approximately $1,772,480. This represents a 81.80% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Gary S. Guthart sold 28,800 shares of the business’s stock in a transaction on Friday, October 24th. The shares were sold at an average price of $547.56, for a total value of $15,769,728.00. Following the completion of the sale, the insider owned 27,027 shares in the company, valued at approximately $14,798,904.12. The trade was a 51.59% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 108,939 shares of company stock worth $60,757,995. 0.70% of the stock is owned by insiders.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- Why Are Stock Sectors Important to Successful Investing?
- Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?
- What does consumer price index measure?
- Gates Foundation Sells MSFT Stock—Should Investors Be Worried?
- The Significance of Brokerage Rankings in Stock Selection
- MarketBeat Week in Review – 12/1 – 12/5
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
